What is insilico medicine? Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, ALS, diabetes, sarcopenia, and aging.Why insilico medicine is the 2022 entrepreneurial company of the year? With its strong overall performance, growing partnerships, focus on innovation, and expertise in end-to-end drug discovery and development, Insilico Medicine earns Frost & Sullivan's 2022 Entrepreneurial Company of the Year Award in the global AI-enabled drug discovery industry.Who are insilico medicine competitors? Competitors of InSilico Medicine include Monogram Health, Harrison.ai and Notable. Where is InSilico Medicine headquarters? InSilico Medicine headquarters is located at 1101 E 33rd St, Baltimore. Where are InSilico Medicine offices?Who are insilicos investors? In 2017, Insilico had raised $8.26 million in funding from investors including Deep Knowledge Ventures, JHU A-Level Capital, Jim Mellon, and Juvenescence.
InSilico Medicine has 124 employees across 2 locations and $306.3 m in total funding,. See insights on InSilico Medicine including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.